Dimerization of the delta opioid receptor: implication for a role in receptor internalization.
about
Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerizationG-protein-coupled receptor heterodimerization modulates receptor functionHeterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patternsUnidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioidsConstitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayersFunctional modulation of human delta opioid receptor by neuropeptide FF.Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3)Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptorFunctional characterization of mutations in melanocortin-4 receptor associated with human obesityHeterodimerization of mu and delta opioid receptors: A role in opiate synergyOligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitationDimerization and phosphorylation of thyrotropin-releasing hormone receptors are modulated by agonist stimulationMu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cellsOligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activationStructural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptorsSerotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressedLigand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-targetPharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid ReceptorsA Role for the Distal Carboxyl Tails in Generating the Novel Pharmacology and G Protein Activation Profile of and Opioid Receptor Hetero-oligomersHomo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors.Lipid raft-mediated regulation of G-protein coupled receptor signaling by ligands which influence receptor dimerization: a computational studyDirect interaction of GABAB receptors with M2 muscarinic receptors enhances muscarinic signaling.Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent proteinToward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers.Search for the "ideal analgesic" in pain treatment by engineering the mu-opioid receptor.Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.Diversifying the repertoire of G protein-coupled receptors through oligomerization.Characterization of the dimerization of metabotropic glutamate receptors using an N-terminal truncation of mGluR1alpha.Opioid-receptor-heteromer-specific trafficking and pharmacology.Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.Structure and regulation of opioid receptors.Making structural sense of dimerization interfaces of delta opioid receptor homodimers.Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand seriesBRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues.Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors.Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanismsThe angiotensin II type 1 receptor and receptor-associated proteins.Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.
P2860
Q24300182-868DDCDA-D01C-4011-A06E-60FE49F518CBQ24603239-36A758A7-8873-4DA4-B5F5-13AA1BB52CD3Q24618881-899F68F1-DA1A-4429-9E67-24E347C6AF57Q24634901-939610A3-BD25-4577-8DE4-D6262BC5F359Q24644172-F295F450-7F31-4225-B1CC-C68B04301403Q24794484-5A7147DD-812F-42D8-B3A6-C32CF5B58E1EQ26783258-2FFD4A67-D6D3-4340-86FF-2B250AF2218FQ28115723-E5E04BBA-C9A9-4E58-B8DB-6EC043944FC3Q28116295-E8EEFE1C-41EA-493D-916C-1835A03E49A1Q28143344-6DA2CBDD-1DC8-4947-8D42-1E5FEDAE19D5Q28202455-5BAA74B7-E47E-4ADC-8EBB-BADF1EE2B7A5Q28218765-460DF0EB-AC3C-4C61-AC21-F58151F002BFQ28344890-F42F696A-FECF-467A-BE7D-05D2F04CBCF3Q28345401-F81509EF-4C6F-4C53-9F7A-80191B45D39FQ28362372-B93F6BEF-5ACE-4DB8-8621-D76033D692F0Q28371036-738C6878-57F6-478C-A602-85E6C742BCB3Q28477403-66E29B51-3E5B-4653-9053-17D065537121Q29542291-D387570F-5808-4B8B-88B5-D6B2BB9DE910Q30053100-922A95A5-4577-4DE5-A10F-4E7FC98B2488Q31777917-43233533-FEBF-4844-83BC-30C5473211B8Q31816606-6A63B4C0-459E-4CD6-BCEC-206779C9A3FAQ33492319-6CF88BD4-34DF-4DC8-9B4C-C49E0753944BQ33637415-8BDFB8DA-7AF0-4341-B080-6924D6D0EF39Q33749457-FF1E41C4-1BC1-486D-BA5E-769CA5C771D8Q33768567-AF50A70E-0D61-4851-9496-75512AD93ECBQ33807778-04D54DFD-A8A6-4202-A3CE-7CAFE1D45B6BQ33863139-A3479F4E-54EE-4D75-8149-2BDC8566418AQ33863332-2F372E79-DC11-4A4F-85E4-A1D071D959E5Q33863637-8734DBA2-5E35-421B-AFE6-F0B74F1410B4Q33978499-35867EA3-08F7-4847-9D92-2DCD2DDB2270Q34051430-6A947B7F-0505-46E7-8219-AAEFA6B5F21EQ34079612-8C974C99-EA23-4C18-9723-3654CD725B46Q34136307-7B0E2696-6449-41EF-80FB-67D161CBC9F4Q34160481-D311786E-DB9B-49AF-9DE3-1D54D0654F3DQ34244966-F63CC7F1-E47C-4A3E-98A4-486F3022374FQ34290644-9FC51826-338A-4182-BBEC-57B2ABB076FFQ34291539-BF936154-7725-40A9-BED8-1F68A09385E7Q34394496-3D1D4531-EF3D-47FB-A12F-1CB1FF997272Q34408092-D8F543AB-BE35-45B3-8031-2F37B9ED48D1Q34424009-7ABEC515-8D76-4F3E-9F30-A15B38B72F86
P2860
Dimerization of the delta opioid receptor: implication for a role in receptor internalization.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Dimerization of the delta opio ...... e in receptor internalization.
@en
Dimerization of the delta opio ...... e in receptor internalization.
@nl
type
label
Dimerization of the delta opio ...... e in receptor internalization.
@en
Dimerization of the delta opio ...... e in receptor internalization.
@nl
prefLabel
Dimerization of the delta opio ...... e in receptor internalization.
@en
Dimerization of the delta opio ...... e in receptor internalization.
@nl
P356
P1476
Dimerization of the delta opio ...... e in receptor internalization.
@en
P2093
P304
26959-26964
P356
10.1074/JBC.272.43.26959
P407
P577
1997-10-01T00:00:00Z